Literature DB >> 1504466

Transforming growth factor-alpha expression in rat experimental hepatocarcinogenesis.

R Pérez-Tomás1, X Mayol, X Culleré, C Díaz Ruiz, J Domingo.   

Abstract

Growth factors in general and transforming growth factor-alpha in particular have been related to cell proliferation and cell differentiation. This study was designed to clarify the distribution pattern of TGF-alpha in chemically-induced hepatocarcinogenesis. Sprague-Dawley rats were subjected to different non-intensive or intensive carcinogenic treatments using diethylnitrosamine (DEN) as carcinogen and ethinyl estradiol (EE) as promoter. The livers were fixed in 2% paraformaldehyde, dehydrated in a series of ethanol solutions, embedded in paraffin and sectioned. In the preneoplastic lesions no TGF-alpha immunoreactive cells were identified, but in some hepatic tumours cell immunostained with TGF-alpha antibody were observed. These results suggest that the cells capable of expressing TGF-alpha constitutively may be involved in neoplastic development in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1504466

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  3 in total

1.  Immunoelectron microscopic localisation of transforming growth factor alpha in rat colon.

Authors:  R Pérez-Tomás; X Culleré; M Asbert; C Díaz-Ruiz
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

2.  Immunohistochemical localization of transforming growth factor-alpha and epidermal growth factor-receptor in the mesonephros and metanephros of the chicken.

Authors:  C Díaz-Ruiz; R Pérez-Tomás; X Culleré; J Domingo
Journal:  Cell Tissue Res       Date:  1993-01       Impact factor: 5.249

3.  Inhibition by transforming growth factor (34-43)-alpha, a TGF-alpha antagonist, of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.

Authors:  M Tatsuta; H Iishi; M Baba; R Hirasawa; K Iseki; H Yano; N Sakai; H Uehara; A Nakaizumi
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.